Fusobacterium nucleatum Outer Membrane Proteins Fap2 and RadD Induce Cell Death in Human Lymphocytes Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

February 13, 2026

  • Microbes
    Microbes

    Microbes are microscopic organisms living in and on the human body, shaping health through digestion, vitamin production, and immune protection. When microbial balance is disrupted, disease can occur. This guide explains key microbe types—bacteria, viruses, fungi, protozoa, and archaea—plus major pathogenic and beneficial examples.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2026-02-13

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This study explored the role of Fusobacterium nucleatum’s outer membrane proteins, Fap2 and RadD, in inducing cell death in human lymphocytes. It focused on how these proteins, identified as part of the type Va autotransporter family, contribute to the bacterium’s virulence. The study examined the mechanisms by which Fap2 and RadD trigger cell death in Jurkat cells, a human T-lymphocyte cell line, and assessed their impact on immune suppression and pathogenicity.

Who was studied?

The study involved Jurkat cells, a human T-lymphocyte cell line, to assess the induction of cell death. The research also involved F. nucleatum strains, including the ATCC 23726 strain and mutants lacking either or both Fap2 and RadD. The study compared wild-type and mutant strains to understand the contributions of Fap2 and RadD to cell death.

What were the most important findings?

The study found that Fap2 and RadD are key virulence factors in Fusobacterium nucleatum, responsible for inducing cell death in human lymphocytes. These outer membrane proteins (OMPs) were shown to trigger cell death in Jurkat cells through a contact-based mechanism, not requiring active protein secretion or translocation. Mutants lacking Fap2 or RadD showed a significant reduction in their ability to induce cell death, with a double mutant lacking both proteins almost completely attenuated in its ability to cause lymphocyte death. Additionally, membrane preparations from F. nucleatum were sufficient to induce cell death, further confirming that these proteins alone, without the need for other bacterial components or effector proteins, are sufficient to activate cell death. The presence of both proteins on the bacterial surface is essential for maximal cell death induction, as each protein alone induced cell death at a reduced level. These findings point to Fap2 and RadD as crucial factors in the bacterium’s immune evasion strategy, allowing it to suppress immune responses and contribute to pathogenicity.

What are the greatest implications of this study?

The findings of this study have significant implications for understanding the pathogenic mechanisms of Fusobacterium nucleatum in periodontal disease and potentially other infections. By identifying Fap2 and RadD as key players in immune suppression, the study opens up new possibilities for targeted therapeutic interventions. In particular, inhibiting the interaction of these proteins with host cells could mitigate F. nucleatum’s ability to evade immune responses and contribute to disease progression. This also suggests that vaccines or other immunotherapies targeting these outer membrane proteins could provide new strategies for controlling infections caused by F. nucleatum, especially in the context of periodontal disease and potentially in systemic infections linked to this bacterium.

Fusobacterium nucleatum

Fusobacterium nucleatum is a Gram-negative, anaerobic bacterium commonly found in the oral cavity, where it plays a crucial role in the formation of biofilms. Beyond its presence in the mouth, Fn is implicated in a variety of systemic conditions, including periodontal disease, colorectal cancer, and inflammatory bowel disease. Known for its ability to coaggregate with other bacteria, Fn's pathogenic potential is magnified in dysbiotic microbial communities, making it a key player in polymicrobial infections. The bacterium utilizes multiple virulence factors such as FadA and Fap2, which facilitate adhesion to host tissues and immune evasion, ultimately contributing to its role in chronic and inflammatory diseases.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.